MXene Loaded With Cu (2‐ x ) Se Nanozyme for Nanocatalytic Tumor Therapy
Chemistry – A European Journal · 2025
DOI: 10.1002/chem.202500574 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – A European Journal, 2025. Verfasst von Mengtian Lu und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry, Chemical Engineering and Resource Utilization, Northeast Forestry University, Harbin, People's Republic of China. Hauptthemen laut MEDLINE: Copper, Nanocomposites, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Heilongjiang Province, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Traditional tumor treatments (surgery, radiotherapy, chemotherapy, etc.) have certain limitations and can have serious negative effects, such as difficulty in cutting out tumors, damage to normal tissues, and complications. Ordinary nanozymes have low catalytic activity and require higher doses for treatment, which can increase in vivo toxicity and side effects. To address these limitations, we developed a Ti 3 C 2 MXene‐based nanocomposite (Ti 3 C 2 /Cu (2‐ x ) Se) integrating Cu (2‐ x ) Se nanozymes with dual enzyme‐mimicking activities (catalase and peroxidase) and MXene's photothermal properties. The Cu (2‐ x ) Se component catalyzes the decomposition of tumor‐overexpressed H 2 O 2 into O 2 and cytotoxic ·OH, alleviating hypoxia while inducing oxidative stress. Simultaneously, MXene's high surface area and photothermal capability enhance nanozyme stability, biocompatibility, and catalytic efficiency under near‐infrared irradiation. Notably, the photothermal effect amplifies enzymatic activity, enabling synergistic nanocatalytic‐photothermal therapy. This synergy not only degrades glutathione to suppress tumor antioxidant defenses but also achieves targeted tumor ablation with reduced dosage requirements. Our work highlights a rational design of MXene‐based nanozymes for enhanced multimodal tumor therapy, offering a paradigm for nanocomposite‐driven disease treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Chemistry, Chemical Engineering and Resource Utilization, Northeast Forestry University, Harbin, People's Republic of China.
- Center of Pharmaceutical Engineering and Technology, Harbin University of Commerce, Harbin, People's Republic of China.
ORCID-Profile: Tiedong Sun
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Heilongjiang Province
- Fundamental Research Funds for the Central Universities
- National Undergraduate Training Programs for Innovations
Zitieren
APA
Lu, M., Zhang, T., Yang, Y., Lin, X., Huang, J., Sun, Y., & Sun, T. (2025). MXene Loaded With Cu (2‐ x ) Se Nanozyme for Nanocatalytic Tumor Therapy. Chemistry – A European Journal. https://doi.org/10.1002/chem.202500574
Vancouver
Lu M, Zhang T, Yang Y, Lin X, Huang J, Sun Y, et al. MXene Loaded With Cu (2‐ x ) Se Nanozyme for Nanocatalytic Tumor Therapy. Chemistry – A European Journal. 2025. doi:10.1002/chem.202500574
BibTeX
@article{Lu2025,
author = {Lu, Mengtian and Zhang, Tianye and Yang, Yue and Lin, Xin and Huang, Jin and Sun, Yuan and Sun, Tiedong},
title = {MXene Loaded With Cu (2‐ x ) Se Nanozyme for Nanocatalytic Tumor Therapy},
journal = {Chemistry – A European Journal},
year = {2025},
doi = {10.1002/chem.202500574}
}
EUVIMED